APO Research
Talk to an analyst

APO RESEARCH · REPORT

Haemophilus b Conjugate Vaccine (Hib)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Haemophilus b Conjugate Vaccine (Hib) Industry Growth and Trends Forecast to 2032

19 December 202574 pages

Choose your research edition.

Industry ResearchHaemophilus b Conjugate Vaccine (Hib) Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Haemophilus b Conjugate Vaccine (Hib) Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Haemophilus b Conjugate Vaccine (Hib) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Haemophilus b Conjugate Vaccine (Hib) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Haemophilus b Conjugate Vaccine (Hib) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Haemophilus b Conjugate Vaccine (Hib) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Haemophilus b Conjugate Vaccine (Hib) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Haemophilus b Conjugate Vaccine (Hib) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Haemophilus b Conjugate Vaccine (Hib) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Haemophilus b Conjugate Vaccine (Hib) include Merck, GSK and Sanofi Pasteur, SA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Haemophilus b Conjugate Vaccine (Hib) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Haemophilus b Conjugate Vaccine (Hib) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Haemophilus b Conjugate Vaccine (Hib) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Haemophilus b Conjugate Vaccine (Hib).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Haemophilus b Conjugate Vaccine (Hib) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Haemophilus b Conjugate Vaccine (Hib) Market by Company

Merck

GSK

Sanofi Pasteur, SA

Haemophilus b Conjugate Vaccine (Hib) Segment by Type

Inactivated Vaccine

Live Attenuated Vaccine

Haemophilus b Conjugate Vaccine (Hib) Segment by Application

Government Institution

Private Sector

Other

Haemophilus b Conjugate Vaccine (Hib) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haemophilus b Conjugate Vaccine (Hib) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Haemophilus b Conjugate Vaccine (Hib) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haemophilus b Conjugate Vaccine (Hib).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Haemophilus b Conjugate Vaccine (Hib) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Haemophilus b Conjugate Vaccine (Hib) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Inactivated Vaccine Table 2. Major Company of Live Attenuated Vaccine Table 3. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2021-2026) & (K Units) Table 5. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Type (2021-2026) Table 8. Global Haemophilus b Conjugate Vaccine (Hib) Price by Type (2021-2026) & (US$/Unit) Table 9. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2027-2032) & (K Units) Table 10. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Type (2027-2032) Table 13. Global Haemophilus b Conjugate Vaccine (Hib) Price by Type (2027-2032) & (US$/Unit) Table 14. North America Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2021-2026) & (K Units) Table 15. North America Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2021-2026) & (K Units) Table 17. Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2021-2026) & (K Units) Table 21. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2021-2026) & (US$ Million) Table 24. Haemophilus b Conjugate Vaccine (Hib) Industry Trends Table 25. Haemophilus b Conjugate Vaccine (Hib) Industry Drivers Table 26. Haemophilus b Conjugate Vaccine (Hib) Industry Opportunities and Challenges Table 27. Haemophilus b Conjugate Vaccine (Hib) Industry Restraints Table 28. Global Haemophilus b Conjugate Vaccine (Hib) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Company (2021-2026) Table 30. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Company (2021-2026) & (K Units) Table 31. Global Haemophilus b Conjugate Vaccine (Hib) Sales Share by Company (2021-2026) Table 32. Global Haemophilus b Conjugate Vaccine (Hib) Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Haemophilus b Conjugate Vaccine (Hib) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Haemophilus b Conjugate Vaccine (Hib) Major Company Production Sites and Headquarters Table 35. Global Haemophilus b Conjugate Vaccine (Hib) Company, Product Type & Application Table 36. Global Haemophilus b Conjugate Vaccine (Hib) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Haemophilus b Conjugate Vaccine (Hib) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Haemophilus b Conjugate Vaccine (Hib) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Region (2021-2026) & (K Units) Table 41. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Region (2021-2026) Table 44. Global Haemophilus b Conjugate Vaccine (Hib) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Region (2027-2032) & (K Units) Table 46. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Region (2027-2032) Table 49. Global Haemophilus b Conjugate Vaccine (Hib) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2021-2026) & (K Units) Table 52. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Application (2021-2026) Table 55. Global Haemophilus b Conjugate Vaccine (Hib) Price by Application (2021-2026) & (US$/Unit) Table 56. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2027-2032) & (K Units) Table 57. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Application (2027-2032) Table 60. Global Haemophilus b Conjugate Vaccine (Hib) Price by Application (2027-2032) & (US$/Unit) Table 61. North America Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2021-2026) & (K Units) Table 62. North America Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2021-2026) & (K Units) Table 64. Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2021-2026) & (K Units) Table 68. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Haemophilus b Conjugate Vaccine (Hib) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Merck Haemophilus b Conjugate Vaccine (Hib) Product Portfolio Table 75. Merck Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Haemophilus b Conjugate Vaccine (Hib) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. GSK Haemophilus b Conjugate Vaccine (Hib) Product Portfolio Table 80. GSK Recent Development Table 81. Sanofi Pasteur, SA Company Information Table 82. Sanofi Pasteur, SA Business Overview Table 83. Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Product Portfolio Table 85. Sanofi Pasteur, SA Recent Development Table 86. North America Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. North America Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2021-2026) & (K Units) Table 88. North America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2021-2026) Table 89. North America Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Country (2027-2032) & (K Units) Table 90. North America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share Forecast by Country (2027-2032) Table 91. North America Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Haemophilus b Conjugate Vaccine (Hib) Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Haemophilus b Conjugate Vaccine (Hib) Market Share by Country (2021-2026) Table 94. North America Haemophilus b Conjugate Vaccine (Hib) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Haemophilus b Conjugate Vaccine (Hib) Market Share Forecast by Country (2027-2032) Table 96. Europe Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2021-2026) & (K Units) Table 98. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2021-2026) Table 99. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Country (2027-2032) & (K Units) Table 100. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Haemophilus b Conjugate Vaccine (Hib) Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Haemophilus b Conjugate Vaccine (Hib) Market Share by Country (2021-2026) Table 104. Europe Haemophilus b Conjugate Vaccine (Hib) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Haemophilus b Conjugate Vaccine (Hib) Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2021-2026) & (K Units) Table 108. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Country (2027-2032) & (K Units) Table 110. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Market Share by Country (2021-2026) Table 114. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Market Share Forecast by Country (2027-2032) Table 116. Latin America Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2021-2026) & (K Units) Table 118. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2021-2026) Table 119. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Country (2027-2032) & (K Units) Table 120. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Haemophilus b Conjugate Vaccine (Hib) Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Haemophilus b Conjugate Vaccine (Hib) Market Share by Country (2021-2026) Table 124. Latin America Haemophilus b Conjugate Vaccine (Hib) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Haemophilus b Conjugate Vaccine (Hib) Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2021-2026) & (K Units) Table 128. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Country (2027-2032) & (K Units) Table 130. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Share by Country (2021-2026) Table 134. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Haemophilus b Conjugate Vaccine (Hib) Distributors List Table 139. Haemophilus b Conjugate Vaccine (Hib) Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Haemophilus b Conjugate Vaccine (Hib) Image Figure 2. Global Haemophilus b Conjugate Vaccine (Hib) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Haemophilus b Conjugate Vaccine (Hib) Market Size (2021-2032) & (US$ Million) Figure 4. Global Haemophilus b Conjugate Vaccine (Hib) Sales (2021-2032) & (K Units) Figure 5. Inactivated Vaccine Image Figure 6. Global Inactivated Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Live Attenuated Vaccine Image Figure 8. Global Live Attenuated Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Haemophilus b Conjugate Vaccine (Hib) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Haemophilus b Conjugate Vaccine (Hib) Market Share by Type 2025 VS 2032 Figure 11. North America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Type in 2025 Figure 12. North America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Type in 2025 Figure 13. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Haemophilus b Conjugate Vaccine (Hib) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Government Institution Image Figure 24. Global Government Institution Sales YoY Growth (2021-2032) & (K Units) Figure 25. Private Sector Image Figure 26. Global Private Sector Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Haemophilus b Conjugate Vaccine (Hib) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Haemophilus b Conjugate Vaccine (Hib) Market Share by Application 2025 VS 2032 Figure 31. North America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Application in 2025 Figure 32. North America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Application in 2025 Figure 33. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Market Share in Value by Application in 2025 Figure 41. North America Haemophilus b Conjugate Vaccine (Hib) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Haemophilus b Conjugate Vaccine (Hib) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Haemophilus b Conjugate Vaccine (Hib) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Haemophilus b Conjugate Vaccine (Hib) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Haemophilus b Conjugate Vaccine (Hib) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Haemophilus b Conjugate Vaccine (Hib) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Haemophilus b Conjugate Vaccine (Hib) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Haemophilus b Conjugate Vaccine (Hib) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Haemophilus b Conjugate Vaccine (Hib) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Haemophilus b Conjugate Vaccine (Hib) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Live Attenuated Vaccine
Applications
  • Government Institution
  • Private Sector
  • Other
Companies covered
  • Merck
  • GSK
  • Sanofi Pasteur, SA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Haemophilus b Conjugate Vaccine (Hib) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Haemophilus b Conjugate Vaccine (Hib) Market by Type
  6. 1.3.1 Inactivated Vaccine
  7. 1.3.2 Live Attenuated Vaccine
  8. 1.4 Global Haemophilus b Conjugate Vaccine (Hib) Market Size by Type
  9. 1.4.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Haemophilus b Conjugate Vaccine (Hib) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Haemophilus b Conjugate Vaccine (Hib) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Haemophilus b Conjugate Vaccine (Hib) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Haemophilus b Conjugate Vaccine (Hib) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Haemophilus b Conjugate Vaccine (Hib) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Haemophilus b Conjugate Vaccine (Hib) Industry Trends
  2. 2.2 Haemophilus b Conjugate Vaccine (Hib) Industry Drivers
  3. 2.3 Haemophilus b Conjugate Vaccine (Hib) Industry Opportunities and Challenges
  4. 2.4 Haemophilus b Conjugate Vaccine (Hib) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Haemophilus b Conjugate Vaccine (Hib) Revenue (2021-2026)
  2. 3.2 Global Top Players by Haemophilus b Conjugate Vaccine (Hib) Sales (2021-2026)
  3. 3.3 Global Top Players by Haemophilus b Conjugate Vaccine (Hib) Price (2021-2026)
  4. 3.4 Global Haemophilus b Conjugate Vaccine (Hib) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Haemophilus b Conjugate Vaccine (Hib) Major Company Production Sites & Headquarters
  6. 3.6 Global Haemophilus b Conjugate Vaccine (Hib) Company, Product Type & Application
  7. 3.7 Global Haemophilus b Conjugate Vaccine (Hib) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Haemophilus b Conjugate Vaccine (Hib) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Haemophilus b Conjugate Vaccine (Hib) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Haemophilus b Conjugate Vaccine (Hib) Tier 1, Tier 2, and Tier 3
4 Haemophilus b Conjugate Vaccine (Hib) Regional Status and Outlook
  1. 4.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Haemophilus b Conjugate Vaccine (Hib) Historic Market Size by Region
  3. 4.2.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Haemophilus b Conjugate Vaccine (Hib) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Haemophilus b Conjugate Vaccine (Hib) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Haemophilus b Conjugate Vaccine (Hib) Forecasted Market Size by Region
  7. 4.3.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Haemophilus b Conjugate Vaccine (Hib) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Haemophilus b Conjugate Vaccine (Hib) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Haemophilus b Conjugate Vaccine (Hib) by Application
  1. 5.1 Haemophilus b Conjugate Vaccine (Hib) Market by Application
  2. 5.1.1 Government Institution
  3. 5.1.2 Private Sector
  4. 5.1.3 Other
  5. 5.2 Global Haemophilus b Conjugate Vaccine (Hib) Market Size by Application
  6. 5.2.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Haemophilus b Conjugate Vaccine (Hib) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Haemophilus b Conjugate Vaccine (Hib) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Haemophilus b Conjugate Vaccine (Hib) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Haemophilus b Conjugate Vaccine (Hib) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Haemophilus b Conjugate Vaccine (Hib) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Haemophilus b Conjugate Vaccine (Hib) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Haemophilus b Conjugate Vaccine (Hib) Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Haemophilus b Conjugate Vaccine (Hib) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Haemophilus b Conjugate Vaccine (Hib) Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Sanofi Pasteur, SA
  14. 6.3.1 Sanofi Pasteur, SA Company Information
  15. 6.3.2 Sanofi Pasteur, SA Business Overview
  16. 6.3.3 Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Product Portfolio
  18. 6.3.5 Sanofi Pasteur, SA Recent Developments
7 North America by Country
  1. 7.1 North America Haemophilus b Conjugate Vaccine (Hib) Sales by Country
  2. 7.1.1 North America Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2021-2026)
  4. 7.1.3 North America Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Haemophilus b Conjugate Vaccine (Hib) Market Size by Country
  6. 7.2.1 North America Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Haemophilus b Conjugate Vaccine (Hib) Market Size by Country (2021-2026)
  8. 7.2.3 North America Haemophilus b Conjugate Vaccine (Hib) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Country
  2. 8.1.1 Europe Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2021-2026)
  4. 8.1.3 Europe Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Haemophilus b Conjugate Vaccine (Hib) Market Size by Country
  6. 8.2.1 Europe Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Haemophilus b Conjugate Vaccine (Hib) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Haemophilus b Conjugate Vaccine (Hib) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales by Country
  2. 9.1.1 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Market Size by Country
  6. 9.2.1 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Haemophilus b Conjugate Vaccine (Hib) Sales by Country
  2. 10.1.1 South America Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2021-2026)
  4. 10.1.3 South America Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Haemophilus b Conjugate Vaccine (Hib) Market Size by Country
  6. 10.2.1 South America Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Haemophilus b Conjugate Vaccine (Hib) Market Size by Country (2021-2026)
  8. 10.2.3 South America Haemophilus b Conjugate Vaccine (Hib) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Country
  2. 11.1.1 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Size by Country
  6. 11.2.1 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Haemophilus b Conjugate Vaccine (Hib) Value Chain Analysis
  2. 12.1.1 Haemophilus b Conjugate Vaccine (Hib) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Haemophilus b Conjugate Vaccine (Hib) Production Mode & Process
  7. 12.2 Haemophilus b Conjugate Vaccine (Hib) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Haemophilus b Conjugate Vaccine (Hib) Distributors
  10. 12.2.3 Haemophilus b Conjugate Vaccine (Hib) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst